{
    "2020-03-30": [
        [
            {
                "time": "2019-03-28",
                "original_text": "药明康德（603259）2019年年报点评：收入增长提速，龙头地位显著",
                "features": {
                    "keywords": [
                        "药明康德",
                        "收入增长",
                        "龙头地位"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-02-15",
                "original_text": "北向资金逆势加仓医药股，抛售美的集团6亿元丨牛熊眼",
                "features": {
                    "keywords": [
                        "北向资金",
                        "加仓",
                        "医药股",
                        "抛售",
                        "美的集团"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-05",
                "original_text": "【万联医药|年报点评】药明康德：主营业务增长稳健，一体化平台优势凸显",
                "features": {
                    "keywords": [
                        "药明康德",
                        "主营业务",
                        "增长稳健",
                        "一体化平台"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "【国信医药】药明康德：收入增长提速，龙头地位显著丨2019年报点评",
                "features": {
                    "keywords": [
                        "药明康德",
                        "收入增长",
                        "龙头地位"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-12",
                "original_text": "异动直击|股东拟减持不超过1%的A股，药明康德跌超6% 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "异动"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-08",
                "original_text": "【民生医药|周报】推荐疫情影响下“供-需”端增速分化带来投资机会",
                "features": {
                    "keywords": [
                        "疫情",
                        "供需",
                        "增速分化",
                        "投资机会"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-03-13",
                "original_text": "药明康德H股跌近7% 股东拟减持A股 拟减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "H股",
                        "减持",
                        "下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-15",
                "original_text": "【东北医药崔洁铭】药明康德（603259）年报点评：业绩稳定增长，四大业务持续赋能",
                "features": {
                    "keywords": [
                        "药明康德",
                        "业绩增长",
                        "四大业务",
                        "赋能"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}